Ardavín Carlos, Amigorena Sebastián, Reis e Sousa Caetano
Department of Cell Biology, Faculty of Biology, Complutense University, 28040, Madrid, Spain.
Immunity. 2004 Jan;20(1):17-23. doi: 10.1016/s1074-7613(03)00352-2.
A recent workshop on "Dendritic Cells: Biology and Therapeutic Applications," sponsored by the Juan March Foundation, brought together basic and clinical research scientists to discuss the mechanisms underlying the control of immune responses and tolerance by dendritic cells (DCs), as well as recent research in cancer immunotherapy based on DC vaccination. Particular emphasis was placed on antigen processing and presentation by DCs, C-type lectin antigen receptors, DC maturation and polarization of T cell responses, the control of immunity versus tolerance by DCs, the developmental origin of DCs, and the use of DCs in cancer immunotherapy.
由胡安· March 基金会主办的最近一次关于“树突状细胞:生物学与治疗应用”的研讨会,汇聚了基础和临床研究科学家,以讨论树突状细胞(DCs)控制免疫反应和耐受性的潜在机制,以及基于 DC 疫苗接种的癌症免疫治疗的最新研究。特别强调了 DCs 的抗原加工和呈递、C 型凝集素抗原受体、DC 成熟和 T 细胞反应的极化、DCs 对免疫与耐受性的控制、DCs 的发育起源以及 DCs 在癌症免疫治疗中的应用。